Chinese researchers develop immunotherapeutic agent for colon cancer
Release time:2024-05-22 02:09:11
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for 。
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano. In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article. The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, said Lu. Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu.
(Editor:Fu Bo)
Related articles
- ST. PETERSBURG, Fla. (AP) — The Tampa Bay Rays placed opening-day starter Zach Eflin on the 15-day i2024-05-22
Efficient Real Madrid making an art form of scoring when least expected
MUNICH (AP) — Real Madrid has made an art form of striking when least expected.Bayern Munich was so2024-05-22Namestnikov and Dillon out for Game 5 against Avs due to injuries as Jets face playoff elimination
WINNIPEG, Manitoba (AP) — Winnipeg forward Vladislav Namestnikov and defenseman Brenden Dillon are r2024-05-22Analysis: McIlroy had a blast in New Orleans. It was just what he needed
Winning the Ryder Cup might have been more valuable than Rory McIlroy realized.McIlroy already was e2024-05-22Climber found dead on Denali, North America's tallest peak
ANCHORAGE, Alaska (AP) — A climber was found dead on North America’s tallest peak, Denali, on Monday2024-05-22Eric Church DOUBLES DOWN on Stagecoach gospel headlining set
Eric Church has doubled down on his Stagecoach headlining set which was branded 'disappointing' by2024-05-22
atest comment